OCLN and acute respiratory distress syndrome: To empirically validate our new candidate biotargets, we used gain and loss of function studies, transgenic mice, and molecular biology (luciferase 3′UTR constructs) to demonstrate the binding and relative contributions of miR-193b-5p to occludin regulation in sepsis-induced ARDS.